Recent News...

Happy Holidays!

Happy Holidays from the MGH Biostatistics Center

Site Redesign

Welcome to our redesigned website!


You are here

Our Projects

Autism Speaks / Autism Treatment Network

The AS ATN is the first bi-national network of hospitals, physicians, researchers, and families at 17 centers across the United States and Canada. We are working together to develop the most effective approach to medical care for children and adolescents affected by autism.

The Network’s goal is to provide comprehensive, high-quality care by teams of healthcare professionals who understand autism spectrum disorders and excel at treating associated medical conditions.

NIH / NHLBI Acute Respiratory Distress Syndrome (ARDS) Network

In order to hasten the development of effective therapy for Acute Respiratory Distress Syndrome (ARDS), the National Heart, Lung, and Blood Institute, National Institutes of Health, initiated a clinical network to carry out multi-center clinical trials of ARDS treatments. The ARDS Network was established as a contract program in 1994 following a national competition. The goal of the Network is to efficiently test promising agents, devices, or management strategies to improve the care of patients with ARDS.

NCI Cancer Genetics Network (CGN)

The Cancer Genetics Network (CGN) is a national research infrastructure designed by the National Cancer Institute (NCI) to support collaborative investigations into the genetic basis of cancer susceptibility, explore mechanisms to integrate this new knowledge into medical practice, and identify ways of addressing the associated psychosocial, ethical, legal, and public health issues.

Early Detection Research Network (ERDN)

The Early Detection Research Network (EDRN), an initiative of the National Cancer Institute (NCI), brings together dozens of institutions to help accelerate the translation of biomarker information into clinical applications and to evaluate new ways of testing cancer in its earliest stages and for cancer risk.

Rare Cancer Genetics Registry (RCGR)

The RCGR, funded by the National Institutes of Health, is a resource for recruitment, planning, and coordination of studies on rare cancers. The mission of the RCGR is to create a registry of participants with rare cancers who are available to participate in research studies, and an accompanying DNA bank for genetics research.

MGH Projects

MGH Department of Medicine Medical Practice Evaluation Center

We partner with the Medical Practice Evaluation Center, beginning with developing preliminary study designs, developing grant proposals and formal study protocols, implementation of studies (both internally supported studies and those supported by grants), analysis, interpretation, and publication of results. All investigators needing biostatistical support should contact Robert Parker, ScD

MGH Cancer Center

We provide the "Biostatistics Core" to the MGH Cancer Center, which is affiliated with the Dana-Farber / Harvard Cancer Center. All investigators needing biostatistical support should contact Dianne Finkelstein, Ph. D.

MGH Department of Radiation Oncology

We provide Biostatistics support to the MGH Department of Radiation Oncology. Please see this webpage for information on who to contact to request support.

Proton Therapy Project

We are the Biostatistics Core for the Proton Therapy Project in the Department of Radiation Oncology.